Abstract 2071P
Background
The objective of this study is to identify the major issues and concerns of cancer patients in Korea related to cancer, anti-cancer therapy, and patient care that are mentioned on social media.
Methods
We collected data from open-access forums, blogs, and social networking sites using professional ISO 20252 certified online access tools. We searched the terms “cancer”, "cancer treatment", and “patient care” and collected social media posts between October 2021 and September 2022, excluding spam and advertisements.
Results
Total 169,575 social media posts were collected. Among the posts, 51% were related to cancer symptoms, concerns following diagnosis, and cancer etiology, while 39% discussed treatment methods, treatment-related side effects, novel therapies, as well as costs. The remaining posts centered on how to manage in daily life. The most frequently mentioned cancer types were breast, lung, colorectal, stomach, and liver cancer, consistent with common cancers in Korea. Concerning the difficulties experienced, 52% reported physical challenges, 42% reported emotional challenges, and 6% discussed daily life issues, such as diet and sexual relationships. Additionally, patients had high expectations for immune checkpoint inhibitors. Patients tend to view clinical trial participation as an alternative when conventional treatments are ineffective and see it positively as a way to participate without financial burden. However, some express safety concerns. Patients frequently shared tips for managing daily life on social media, such as healthy eating, taking supplements, and light exercise to maintain physical strength.
Conclusions
Our findings suggest that cancer patients in Korea frequently use social media for information. The high frequency of emotional difficulties mentioned indicates that patients face persistent emotional challenges throughout the cancer journey. This study underscores the potential benefits of analyzing social media posts by cancer patients, providing valuable insights for healthcare professionals and patients. Moreover, it emphasizes the importance of the developing and delivering professional information on daily life management for cancer patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Korean Society of Medical Oncology.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2045P - Patient Reported Outcome Measures (PROMs) capturing therapy adherence of cancer patients: A systematic literature review
Presenter: Luise Richter
Session: Poster session 06
2046P - The importance of communicating bad news in medical education
Presenter: Georgios Goumas
Session: Poster session 06
2047P - Neutrop: A descriptive, observational study for G-CSF prescription in daily practice
Presenter: Florian Scotté
Session: Poster session 06
2048P - Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Presenter: Lotte Hulskotte
Session: Poster session 06
2049P - Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Presenter: Gisele Moreira
Session: Poster session 06
2050P - Integrating ayurveda herbs with standard of care for management of cancer or cancer treatment related anorexia
Presenter: Yogesh Bendale
Session: Poster session 06
2051P - E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Presenter: Patricia Rioja Viera
Session: Poster session 06
2052P - Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Presenter: Camila Oliveira
Session: Poster session 06
2053P - Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Presenter: Kalysta Borges
Session: Poster session 06
2054P - Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Presenter: Colin Vercueil
Session: Poster session 06